6628 — Transcenta Holding Share News
0.000.00%
Last trade - 00:00- HK$274.26m
- HK$418.66m
- CNY7.44m
Brief: Transcenta Holding Says Unit To Sell CDMO Assets For RMB190.0 Million
Brief: Transcenta Holding To Revert Assets To Lilly For $4 Million Cash
Brief: Transcenta Therapeutics Appoints Dr. Christopher Hwang As Head Of Global Partnerships For Hicb Platform
Brief: Transcenta Announces Collaboration And Non-Exclusive Licensing Agreement With Eirgenix Inc.
IVD rises on blockchain funding deal for oncology treatments
Brief: IVD Medical Announces Signing Of Strategic Cooperation Agreement With Transcenta Holding
Brief: Transcenta To Place 14.4 Million Shares At HK$4.33 Per Share
Brief: Transcenta Holding Ltd Posts HY Loss Of RMB109.8 Mln
Brief: Transcenta Posts HY Loss RMB133.7 Million
Brief: Transcenta Holding Limited Posts H1 Revenue RMB 4.6 Million
Brief: Transcenta Holding Says Xueming Qian Appointed As Chairman
Brief: Transcenta Says Collaboration With Agilent Technologies To Develop A Claudin18.2 Companion Diagnostic
Brief: Transcenta Says FY Loss And Total Comprehensive Expenses RMB465.7 Million
Brief: Transcenta Holding Limited Says Receival Of Clearance From FDA
Brief: Transcenta Holding Posts HY Revenue RMB36.1 Million
Brief: Transcenta Holding Receives Approval To Initiate Phase II Clinical Trial Of TST002
Brief: Transcenta Says IFRS Revenue Increased To RMB101.9 Million For Year
Brief: Transcenta Says U.S. FDA Granted Orphan Drug Designation To Osemitamab (Tst001)
Brief: Transcenta Holding Announces IND Clearance From China's NMPA For Tst003